Used primarily in the treatment of tuberculosis, this compound is a key antimycobacterial agent that inhibits the synthesis of mycolic acids, essential components of the mycobacterial cell wall. It is effective against actively growing tuberculosis bacteria and is commonly administered orally or intravenously as part of combination therapy to prevent drug resistance. It can also be used in the management of latent TB infection to reduce the risk of progression to active disease. Additionally, it has been employed in some laboratory settings for the synthesis of various heterocyclic compounds and as a building block in medicinal chemistry.